National health spending is expected to grow an average 5.8% annually from 2014-2024, due to coverage expansions under the Affordable Care Act, anticipated economic growth and an aging population, the Centers for Medicare & Medicaid Services reported today in Health Affairs. “However, these projected growth rates are significantly lower than those observed over the three decades prior to the recent recession,” said Sean Keehan, a senior economist in CMS’s Office of the Actuary. Health spending is projected to grow 1.1% faster than gross domestic product per year during this period, raising the health care share of GDP from 17.4% in 2013 to 19.6% by 2024. CMS projects health care spending to have grown 5.5% in 2014, primarily due to insurance coverage expansions and a sharp rise in prescription drug spending, which is projected to have accelerated from 2.5% in 2013 to 12.6% in 2014. Spending for hospital care is expected to have grown 4.4% in 2014, similar to 2013. The report also notes that hospital price growth, as measured by the Producer Price Index, decelerated from 2.2% in 2013 to 1.4% in 2014 – the slowest rate since 1998.         

Related News Articles

Headline
The South Carolina measles outbreak has grown to 950 cases, the state’s Department of Public Health reported Feb. 13. Of those, 246 cases are under age 5, 611…
Headline
The Department of Health and Human Services Feb. 13 issued a request for information on a new 340B rebate model program. The RFI said HHS’ Health Resources and…
Headline
The U.S. District Court for the Eastern District of Texas Feb. 12 vacated a final rule by the Federal Trade Commission that changed premerger notification…
Perspective
Public
Abraham Lincoln, among those whose legacy we honor with Presidents Day next week, might have put it this way: Thirteen score and three days from now… …
Headline
A bipartisan letter supported by the AHA was sent by members of Congress Feb. 11 to the Department of Homeland Security, urging the agency to…
Headline
The Administration for Strategic Preparedness and Response has launched a $100 million competition to support the development of antiviral drug therapies…